Literature DB >> 6970300

Pulmonary Langerhans' cells in patients with fibrotic lung disorders.

O Kawanami, F Basset, V J Ferrans, P Soler, R G Crystal.   

Abstract

Langerhans' cells were found in lung biopsies in one of nine control patients and in 20 of 160 patients with fibrotic lung disorders, including 13 of 56 patients with idiopathic pulmonary fibrosis, two of nine patients with collagen vascular diseases, two of seven patients with hypersensitivity pneumonitis, and each of three patients with end stage fibrosis of uncertain cause. Langerhans' cells were not found in any of the 41 patients with sarcoidosis, the 35 patients with interstitial lung diseases associated with inhalation of inorganic dusts, the seven patients with pulmonary lymphangioleiomyomatosis, or the two patients with chronic eosinophilic pneumonia. In the control patient, Langerhans' cells were found between epithelial cells in bronchioles. In patients with fibrotic lung disorders, Langerhans' cells were found in the epithelial layer of bronchioles and alveoli containing proliferating epithelial cells, i.e., either cuboidal epithelial cells of bronchiolar origin or type II alveolar epithelial cells. Severe fibrosis or squamous metaplasia were not prerequisites for the presence of Langerhans' cells. The motility of Langerhans' cells apparently was restricted, as they were not found in the air spaces in any of the biopsies, and they were not recovered from bronchoalveolar lavage fluid of any of the 97 patients studied, even though some of these patients had relatively numerous Langerhans' cells in lung biopsies. These observations are in sharp contrast to those in pulmonary histiocytosis X, in which histiocytosis X cells (HX cells) occur in granulomas, in alveolar interstitium, and between epithelial cells of the lower respiratory system. HX cells also migrate into air spaces, as shown by their occurrence in bronchoalveolar lavage fluid. The HX bodies in HX cells are morphologically similar to Langerhans' cell granules, but are more numerous and pleomorphic. HX cells are considered to be reactive or activated Langerhans' cells.

Entities:  

Mesh:

Year:  1981        PMID: 6970300

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

Review 1.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

2.  Pulmonary histiocytosis X.

Authors:  T W Marcy; H Y Reynolds
Journal:  Lung       Date:  1985       Impact factor: 2.584

3.  Langerhans' cell histiocytosis associated with Hodgkin's disease: a case report.

Authors:  M S Shin; S E Buchalter; K J Ho
Journal:  J Natl Med Assoc       Date:  1994-01       Impact factor: 1.798

4.  Histiocytosis X arising in Hodgkin's disease: immunophenotypic characterization with a panel of monoclonal antibodies.

Authors:  A Coli; G Bigotti; S Ferrone
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid.

Authors:  S Chollet; P Soler; P Dournovo; M S Richard; V J Ferrans; F Basset
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

6.  Hypersensitivity pneumonitis in man. Light- and electron-microscopic studies of 18 lung biopsies.

Authors:  O Kawanami; F Basset; R Barrios; J G Lacronique; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

7.  Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies.

Authors:  P Soler; S Chollet; C Jacque; Y Fukuda; V J Ferrans; F Basset
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

8.  S-100 protein-positive Langerhans cells in various human lung cancers, especially in peripheral adenocarcinomas.

Authors:  T Nakajima; T Kodama; M Tsumuraya; Y Shimosato; T Kameya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

Review 9.  Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung.

Authors:  B E Lehnert
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

10.  Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura.

Authors:  K Sertl; T Takemura; E Tschachler; V J Ferrans; M A Kaliner; E M Shevach
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.